Zobrazeno 1 - 10
of 36
pro vyhledávání: '"George Pasparakis"'
Autor:
Aikaterini Gialouri, Sofia Falia Saravanou, Konstantinos Loukelis, Maria Chatzinikolaidou, George Pasparakis, Nikolaos Bouropoulos
Publikováno v:
Gels, Vol 9, Iss 12, p 984 (2023)
In this work, a sodium alginate-based copolymer grafted by thermoresponsive poly(N-isopropylacrylamide) (PNIPAM) chains was used as gelator (Alg-g-PNIPAM) in combination with methylcellulose (MC). It was found that the mechanical properties of the re
Externí odkaz:
https://doaj.org/article/0123696b577e48ac9b46c685edc24302
Autor:
Mina Emamzadeh, George Pasparakis
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-15 (2021)
Abstract Pancreatic cancer is one of the most lethal malignancies with limited therapeutic options and dismal prognosis. Gemcitabine is the front-line drug against pancreatic cancer however with limited improvement of therapeutic outcomes. In this st
Externí odkaz:
https://doaj.org/article/34bd49c34d0e42a5939a788645c33ee5
Publikováno v:
Pharmaceutical Sciences and Research, Vol 7, Iss 1, Pp 34-44 (2020)
A series of new core-shell fibers were developed containing anticancer drugs (5-fluorouracil or ferulic acid) and their cyclodextrin inclusion complexes, with a gadolinium-based magnetic resonance imaging (MRI) contrast agent. These were prepared by
Externí odkaz:
https://doaj.org/article/4971d61e76734e9e9af20c155359f38e
Autor:
Christopher Barnett, Fanny Joubert, Alexandra Iliopoulou, Raúl Sánchez Álvarez, George Pasparakis
Publikováno v:
Molecular Pharmaceutics. 20:1818-1841
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1881950e5cd629e611cbd0a27c17bf09
https://doi.org/10.1021/acs.molpharmaceut.2c01012
https://doi.org/10.1021/acs.molpharmaceut.2c01012
Autor:
Sofia Falia Saravanou, Konstantinos Ioannidis, Andreas Dimopoulos, Alexandra Paxinou, Fotoula Kounelaki, Sevilli Maria Varsami, Constantinos Tsitsilianis, Ioannis Papantoniou, George Pasparakis
Publikováno v:
Carbohydrate Polymers. 312:120790
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b8fd29c42331e49974e762621782189e
https://doi.org/10.1016/j.carbpol.2023.120790
https://doi.org/10.1016/j.carbpol.2023.120790
Publikováno v:
European Polymer Journal. 189:111977
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2a7876c78fc3c2d0b1ce1c02bea9b1c6
https://doi.org/10.1016/j.eurpolymj.2023.111977
https://doi.org/10.1016/j.eurpolymj.2023.111977
Autor:
Fanny Joubert, George Pasparakis
Publikováno v:
Journal of Polymer Science. 58:2010-2021
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::583017ab767ea170e7b3d50e47a80c7a
https://doi.org/10.1002/pol.20200303
https://doi.org/10.1002/pol.20200303
Publikováno v:
Pharmaceutical Sciences and Research, Vol 7, Iss 1, Pp 34-44 (2020)
A series of new core-shell fibers were developed containing anticancer drugs (5-fluorouracil or ferulic acid) and their cyclodextrin inclusion complexes, with a gadolinium-based magnetic resonance imaging (MRI) contrast agent. These were prepared by
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dd903cb0b2bf4e46cb193927aceab8d4
https://scholarhub.ui.ac.id/psr/vol7/iss1/5/
https://scholarhub.ui.ac.id/psr/vol7/iss1/5/
Publikováno v:
Acta Biomaterialia. 90:21-36
Biologically inspired materials with tunable bio- and physicochemical properties provide an essential framework to actively control and support cellular behavior. Cell membrane remodeling approaches benefit from the advances in polymer science and bi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::79590f69667f21d001cd8b2330cb4f2e
https://doi.org/10.1016/j.actbio.2019.04.013
https://doi.org/10.1016/j.actbio.2019.04.013
Autor:
George Pasparakis, Mina Emamzadeh
Publikováno v:
Scientific Reports
Scientific Reports, Vol 11, Iss 1, Pp 1-15 (2021)
Scientific Reports, Vol 11, Iss 1, Pp 1-15 (2021)
Pancreatic cancer is one of the most lethal malignancies with limited therapeutic options and dismal prognosis. Gemcitabine is the front-line drug against pancreatic cancer however with limited improvement of therapeutic outcomes. In this study we en
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a489af73a59e5c2ca1a2919e9bed6dc9
http://europepmc.org/articles/PMC8087785
http://europepmc.org/articles/PMC8087785